{{ variable.name }} : {{ variable.values[selectedVariantsIndex[variable_index]].name }}
Quantidade:
PT-141, known generically as bremelanotide, is a synthetic peptide that activates melanocortin receptors (primarily MC4R) in the central nervous system to boost sexual desire and arousal.
How It Works vs. Other Medications
• Brain-Based (PT-141): It acts on the hypothalamus and central nervous system to stimulate the natural "want" and sexual motivation, functioning like the ignition of a car.
• Vascular (Viagra/Cialis): PDE5 inhibitors like sildenafil or tadalafil work peripherally by relaxing blood vessels to improve blood flow, functioning like fuel delivery rather than creating desire.
Approved Indications & Uses
• FDA Approval: Approved under the brand name Vyleesi as a subcutaneous injection for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
• Off-Label / Men's Health: Often used off-label or in specialized men's health clinics for low libido, erectile dysfunction, or for patients who do not respond to traditional PDE5 inhibitors.
Dosage & Administration
• Timing: Typically administered 30 to 60 minutes before anticipated sexual activity.
• Form: The FDA-approved product is an on-demand subcutaneous injection, though compounded or research-market versions (such as troches or nasal sprays) are sometimes marketed outside of official prescription channels.
Side Effects & Safety Precautions
• Common Side Effects: Nausea (frequent, especially in women), flushing, headache, and nasal congestion.
• Contraindications: It is unsafe and contraindicated for people with uncontrolled high blood pressure or cardiovascular disease.
• Quality Warning: Buying unverified PT-141 from online gray-market research-chemical vendors carries risks regarding purity, sterility, and accurate dosing